Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Biovex, Inc.
EIR
•Biovex, Inc.•February 13, 2015

Biovex, Inc. – FDA EIR, Feb 13, 2015

Record Details

An FDA pre-license inspection was conducted at BioVex Inc. (Amgen Woburn) from February 10-13, 2015, under the regulatory framework for Biologics License Applications (BLA 125518) of talimogene laherparepvec (T-Vec), a product for melanoma treatment. The inspection, equivalent to a Level I assessment for somatic cell and gene therapy products, aimed to evaluate the manufacturing facility. Upon conclusion, the FDA issued a Form 483 with three observations. These included improper aseptic technique by a manufacturing operator in an ISO biological safety cabinet, specifically concerning wipe usage during cleaning and obstruction of a vent grill. Additionally, the Biosafety Cabinet Logbook for a critical area lacked documented evidence of required monthly reviews. The third observation noted that a validated process hold period for an intermediate step was not incorporated into the media fill studies. All identified issues were discussed with firm management, necessitating corrective actions to ensure compliance with good manufacturing practices ahead of product commercialization.

Company
Biovex, Inc.
Inspection date
February 13, 2015
Product type
Drugs
Office
Center for Biologics Evaluation and Research
People
  • Nancy Waites (issuing_officer)
  • Rabia Ballica (issuing_officer)
View Company Profile

ID · 3aa968ce-6741-4c2d-95e4-0a0348e5461a

Violation Codes3
21 CFR 21121 CFR 820.5021 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Biovex, Inc.
  • 483 - 2019-09-27September 27, 2019
  • 483 - 2015-02-13February 13, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biovex, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.